Fresenius SE & Co. KGaA

ISIN DE0005785604 Symbol FRE Industry Medical Care Facilities Sector Healthcare
Fresenius Price
43.90EUR 0.95%
1y Low: 31.0
1y High: 45.5
1y Low: 31.0
1y High: 45.5
fresenius.com
Market Cap
25.8 B USD
Dividend Yield
2.2%
Performance 1y
15.89 %
PER
13.0

Fresenius Stock Chart

Fresenius Dividend Chart

Fresenius Dividend Calendar

Year # Div. Div. Paid Div. Yield Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 1 0.88 EUR 4.0 %
2020 2 1.68 EUR 4.3 %
2019 1 0.80 EUR 1.7 %
2018 1 0.75 EUR 1.9 %
2017 1 0.62 EUR 1.0 %
2016 2 1.10 EUR 1.6 %
2015 1 0.44 EUR 0.7 %
2014 1 0.42 EUR 1.1 %
2013 1 0.37 EUR 0.4 %
2012 1 0.32 EUR 0.4 %
2011 1 0.29 EUR 0.5 %
2010 1 0.25 EUR 0.5 %
2009 1 0.23 EUR 0.6 %
2008 1 0.22 EUR 0.8 %
2007 1 0.19 EUR 0.4 %
2006 1 0.16 EUR 0.1 %
2005 1 0.15 EUR 0.2 %
2004 1 0.13 EUR 0.2 %
2003 1 0.12 EUR 0.2 %
2002 1 0.11 EUR 0.4 %
2001 1 0.047 EUR 0.1 %
2000 1 0.083 EUR 0.1 %
1999 1 0.069 EUR 0.1 %
1998 1 0.058 EUR 0.0 %
1997 1 0.050 EUR 0.0 %
1996 1 0.042 EUR 0.0 %
1995 1 0.036 EUR 0.0 %
1994 1 0.024 EUR 0.0 %

Fresenius Performance

1 Week
1 Month
6 Months
21.64 %
Year to Date
14.09 %
1 Year
15.89 %
5 Years
33.01 %

Fresenius Revenue, EBIT, and Income

Fresenius Margins

Fresenius Shares Outstanding

Useful Links

Search Twitter: $FRE, #FRE

Fresenius Company Info

Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs, including intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products that are used in the collection and processing of blood components, as well as in transfusion medicine and cell therapy. As of December 31, 2019, this segment operated 86 hospitals, approximately 125 outpatient clinics, and 8 prevention centers. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. Fresenius SE & Co. KGaA has a strategic partnership with Humacyte Inc. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Fresenius Price to Earnings Ratio (PE Ratio): 13.0

The current Price to Earnings Ratio of Fresenius is 13.0.
The PE Ratio is calcluated by dividing the current Fresenius share price (43.90 EUR) by the earnings per share (3.1).

Fresenius Dividend Yield: 2.2%

The current Dividend Yield of Fresenius is 2.2%.

Fresenius Market Cap: 25.8 B USD

The current market cap of Fresenius is 25.8 B USD.

Fresenius Stock Price: 43.90 EUR

The current stock price of Fresenius is 43.90 EUR (51.47 USD).

Fresenius ISIN: DE0005785604

The ISIN (International Securities Identification Number) of Fresenius is DE0005785604.

Fresenius Ticker Symbol: FRE

The ticker symbol of Fresenius is FRE.

Fresenius Address

The address of the Fresenius HQ is Else-Kröner-Strasse 1, 61352 Bad Homburg vor der Höhe, Germany.